Clinical Trial Update: An Open Label Evaluation of the Pharmacokinetics and Safety of Single Dose Intravenous Azithromycin in Preterm Neonates [Phase 1]

View source ↗

Summary

Open-label Phase 1 study assessing the pharmacokinetics and safety of a single intravenous dose of azithromycin in preterm neonates with Ureaplasma infection or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infection
• Ureaplasma Infection

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Ureaplasma, Bacterial Infection | Phase 1 | Status: COMPLETED